#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile chronic myelomonocytic leukaemia Angiosarcoma recurrent Waldenstrom's macroglobulinaemia recurrent Fibrosarcoma metastatic Acute respiratory distress syndrome Retinoblastoma Soft tissue necrosis Gastrointestinal cancer metastatic Tourette's disorder Cryoglobulinaemia Pleural mesothelioma Familial haemophagocytic lymphohistiocytosis Chronic myeloid leukaemia (in remission) Dilated cardiomyopathy Human papilloma virus immunisation More trials…

    Learn about Rare Diseases

    Progressive multifocal leukoencephalopathy – Trials in Disease Epidermolysis bullosa – Trials in Disease Retinitis pigmentosa – Life with Disease Phenylketonuria – Treatment Toxic epidermal necrolysis – Diagnostics Chondrosarcoma metastatic – Trials in Disease Cerebral arteriovenous malformation haemorrhagic Marfan’s syndrome Mucopolysaccharidosis III Waldenstrom’s macroglobulinaemia recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HALOBETASOL PROPIONATE Soya Oil RLY-2608 177LU-PSMA-I&T PICLIDENOSON Midomafetamine Hydrochloride Taminadenant Sqy51 Teriflunomide Sacubitril Valsartan Istaroxime Levetiracetam Povidone Clindamycin Phosphate Sorafenib Tosilate NADOFARAGENE FIRADENOVEC Midodrine Hydrochloride Isosorbide Dinitrate 18F-Fludarabine VX-407 More therapies…

    Learn about Your Condition

    Cataract Oxygen saturation Essential hypertension Acute cardiac event Head and neck cancer Papilloma viral infection Factor IX deficiency Renal cancer stage IV Eosinophilic oesophagitis Thyroid mass Malignant melanoma stage III Diabetic autonomic neuropathy Malignant melanoma stage IV Vulvovaginal pruritus Post procedural complication More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut de Cancérologie Hématologie Universitaire…

Institut de Cancérologie Hématologie Universitaire de Saint Etienne (iCHUSE)

Avenue Albert Raimond, Saint Priest En Jarez, 42270, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Dactinomycin
    • Vinorelbine Tartrate
    • Regorafenib
    Austria Belgium Czechia Denmark Finland France +10

  • Study on Zoledronic Acid Use After Stopping Denosumab in Women with Postmenopausal Osteoporosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Zoledronic Acid
    France

  • Study on Treating Acute Osteomyelitis in Children with Amoxicillin and Cloxacillin Compared to Standard Hospital Care

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteomyelitis
    • Osteomyelitis acute
    Investigated Drugs:
    • Amoxicillin
    • Cefazolin
    • Clavulanic Acid
    France

  • Study on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis

    Recruiting

    3 1
    Investigated Drugs:
    • Oxymetazoline Hydrochloride
    Bulgaria Czechia France Germany Hungary Italy +4

  • Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Busulfan
    • Carboplatin
    Austria Belgium Czechia Denmark Finland France +13

  • Study on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy

    Recruiting

    3 1
    Investigated Diseases:
    • HER2 positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • L-Isoleucyl-L-Isoleucyl-L-Seryl-L-Alanyl-L-Valyl-L-Valyl-Glycyl-L-Isoleucyl-L-Leucine
    • Sargramostim
    Austria Belgium France Germany Ireland Italy +4

  • Study on Early Immunotherapy with Human Normal Immunoglobulin, Cyclophosphamide, and Methylprednisolone for Patients with Anti-Hu Paraneoplastic Sensory Neuropathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Paraneoplastic neurological syndrome
    Investigated Drugs:
    • Mesna
    • Methylprednisolone Hemisuccinate
    • Human Normal Immunoglobulin (Iv)
    France

  • Study Comparing Methylprednisolone and Methoxsalen for Treating Grade II Acute Graft-Versus-Host Disease in Adult Stem Cell Transplant Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    • Acute graft versus host disease in skin
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Methoxsalen
    • Posaconazole
    France

  • Study Comparing Trametinib and Vinblastine for Children and Young Adults with Newly Diagnosed Low-Grade Glioma with Wild-Type BRAF Gene

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Trametinib
    • Vinblastine Sulfate
    France

  • Study on the Effectiveness of Lutetium (177Lu) Vipivotide Tetraxetan with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Apalutamide
    • Darolutamide
    • Abiraterone Acetate
    Belgium France Ireland Italy The Netherlands Spain
Previous Page
1 … 12 13 14 15 16 … 46
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!